These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 26530439)

  • 1. Paxillin is positively correlated with the clinicopathological factors of colorectal cancer, and knockdown of Paxillin improves sensitivity to cetuximab in colorectal cancer cells.
    Du C; Wang X; Zhang J; Liu X; Zhu J; Liu Y
    Oncol Rep; 2016 Jan; 35(1):409-17. PubMed ID: 26530439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paxillin knockdown suppresses metastasis and epithelial‑mesenchymal transition in colorectal cancer via the ERK signalling pathway.
    Wen L; Zhang X; Zhang J; Chen S; Ma Y; Hu J; Yue T; Wang J; Zhu J; Wu T; Wang X
    Oncol Rep; 2020 Sep; 44(3):1105-1115. PubMed ID: 32705241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of paxillin induced by miR-137 suppression promotes tumor progression and metastasis in colorectal cancer.
    Chen DL; Wang DS; Wu WJ; Zeng ZL; Luo HY; Qiu MZ; Ren C; Zhang DS; Wang ZQ; Wang FH; Li YH; Kang TB; Xu RH
    Carcinogenesis; 2013 Apr; 34(4):803-11. PubMed ID: 23275153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation of paxillin confers cisplatin resistance in non-small cell lung cancer via activating ERK-mediated Bcl-2 expression.
    Wu DW; Wu TC; Wu JY; Cheng YW; Chen YC; Lee MC; Chen CY; Lee H
    Oncogene; 2014 Aug; 33(35):4385-95. PubMed ID: 24096476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bcl-2 stabilization by paxillin confers 5-fluorouracil resistance in colorectal cancer.
    Wu DW; Huang CC; Chang SW; Chen TH; Lee H
    Cell Death Differ; 2015 May; 22(5):779-89. PubMed ID: 25323586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Paxillin Expression and Phosphorylation on Colorectal Cancer Prognosis and Metastasis.
    Zheng H; Tsunedomi R; Xu M; Zhang Y; Kishi H; Kobayashi S; Tomochika S; Nakajima M; Matsui H; Tokumitsu Y; Shindo Y; Iida M; Ioka T; Nagano H
    Anticancer Res; 2024 Feb; 44(2):511-520. PubMed ID: 38307570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of paxillin in colorectal carcinoma and its relationship to clinicopathological features.
    Yin H; Zhang Q; Wang X; Li T; Wan Y; Liu Y; Zhu J
    Chin Med J (Engl); 2014; 127(3):423-9. PubMed ID: 24451945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paxillin promotes colorectal tumor invasion and poor patient outcomes via ERK-mediated stabilization of Bcl-2 protein by phosphorylation at Serine 87.
    Huang CC; Wu DW; Lin PL; Lee H
    Oncotarget; 2015 Apr; 6(11):8698-708. PubMed ID: 25826088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FoxO3a confers cetuximab resistance in RAS wild-type metastatic colorectal cancer through c-Myc.
    Yu Y; Guo M; Wei Y; Yu S; Li H; Wang Y; Xu X; Cui Y; Tian J; Liang L; Peng K; Liu T
    Oncotarget; 2016 Dec; 7(49):80888-80900. PubMed ID: 27825133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal expression of paxillin correlates with tumor progression and poor survival in patients with gastric cancer.
    Chen DL; Wang ZQ; Ren C; Zeng ZL; Wang DS; Luo HY; Wang F; Qiu MZ; Bai L; Zhang DS; Wang FH; Li YH; Xu RH
    J Transl Med; 2013 Nov; 11():277. PubMed ID: 24180516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FAK, Src and p-Paxillin expression is decreased in liver metastasis of colorectal carcinoma patients.
    Mantonakis E; Giaginis C; Pikoulis E; Felekouras E; Patsouris E; Liakakos T; Papalampros E; Theocharis S
    J BUON; 2017; 22(5):1097-1106. PubMed ID: 29135089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The overexpression of PXN promotes tumor progression and leads to radioresistance in cervical cancer.
    Liu Q; Wang J; Tang M; Chen L; Qi X; Li J; Yu J; Qiu H; Wang Y
    Future Oncol; 2018 Feb; 14(3):241-253. PubMed ID: 29318915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UbcH10 expression can predict prognosis and sensitivity to the antineoplastic treatment for colorectal cancer patients.
    Cacciola NA; Calabrese C; Malapelle U; Pellino G; De Stefano A; Sepe R; Sgariglia R; Quintavalle C; Federico A; Bianco A; Uchimura Bastos A; Milone M; Bellevicine C; Milone F; Carlomagno C; Selvaggi F; Troncone G; Fusco A; Pallante P
    Mol Carcinog; 2016 May; 55(5):793-807. PubMed ID: 25917796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paxillin predicts survival and relapse in non-small cell lung cancer by microRNA-218 targeting.
    Wu DW; Cheng YW; Wang J; Chen CY; Lee H
    Cancer Res; 2010 Dec; 70(24):10392-401. PubMed ID: 21159652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paxillin promotes tumor progression and predicts survival and relapse in oral cavity squamous cell carcinoma by microRNA-218 targeting.
    Wu DW; Chuang CY; Lin WL; Sung WW; Cheng YW; Lee H
    Carcinogenesis; 2014 Aug; 35(8):1823-9. PubMed ID: 24894864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary and acquired resistance of colorectal cancer cells to anti-EGFR antibodies converge on MEK/ERK pathway activation and can be overcome by combined MEK/EGFR inhibition.
    Troiani T; Napolitano S; Vitagliano D; Morgillo F; Capasso A; Sforza V; Nappi A; Ciardiello D; Ciardiello F; Martinelli E
    Clin Cancer Res; 2014 Jul; 20(14):3775-86. PubMed ID: 24812410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of Paxillin Correlates with Tumor Progression and Predicts Poor Survival in Glioblastoma.
    Sun LH; Yang FQ; Zhang CB; Wu YP; Liang JS; Jin S; Wang Z; Wang HJ; Bao ZS; Yang ZX; Jiang T
    CNS Neurosci Ther; 2017 Jan; 23(1):69-75. PubMed ID: 27637748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of paxillin on HCT-8 human colorectal cancer cells.
    Jun Q; Zhiwei W; Lilin M; Jing K; Qichao N
    Hepatogastroenterology; 2011; 58(112):1951-5. PubMed ID: 21940355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitomycin C retardation of corneal fibroblast migration via sustained dephosphorylation of paxillin at tyrosine 118.
    Chen TC; Lai CH; Chang JL; Chang SW
    Invest Ophthalmol Vis Sci; 2012 Mar; 53(3):1539-47. PubMed ID: 22323460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [ADAM17 knockdown increases sensitivity of SW480 cells to cetuximad].
    Chen Y; Zheng K; Chen Z; Feng H; Fang W; Huang Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Nov; 38(11):1366-1371. PubMed ID: 30514687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.